77858-21-0O=Cc1c(O)cccc1OCCCCC(=O)ONSUDGNLOXMLAEB-UHFFFAOYSA-NVelaresol is a small molecule drug. Velaresol has a monoisotopic molecular weight of 238.08 Da.
77858-21-0DTXSID30228472CHEMBL2107643Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military.
UsesVelaresol (BW 12C) is a potent left-shifting anti-sickling compound in vitro[1]. Sickle cell disease is an inherited disorder of the hemoglobin molecule. When hemoglobin molecules are exposed to a variety of environments, the red blood cell hemoglobin polymerizes, twists, and morphs into a sickle shape.